English Deutsch 中文
XinTech
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
XinTech
Menu Deutsch 中文

Vivo Ventures Closes $375 Million US-China Life Science Fund

Jan. 2, 2012

Vivo Ventures, a Californian healthcare investment firm that invests in both US and Chinese life science companies, closed its seventh fund, Vivo Ventures VII, at $375 million. In the US, the fund will target companies in the later stage of development. Its China investments will seek enterprises that are producing revenues.